Verily, Walgreens partner to take on chronic conditions
December 26, 2018 / Tom Sullivan
Alphabet subsidiary Verily and Walgreens revealed plans to collaborate with on several fronts to improve care for people with chronic conditions. There are several aspects of the partnership: Walgreens is now the first choice pharmacy partner for Verily. The companies will look into emerging technologies, such as sensors and software to screen and diagnose disease. They are undertaking a “shared goal of scaling deployment at Walgreens retail locations.” One of the first agenda items is to pilot a medication adherence program. Verily’s joint venture with Sanofi, named Onduo, will launch a virtual diabetes tool for Walgreens employees and family members to use. “These initiatives are part of a broader strategic alliance designed to combine Verily’s healthcare technology innovation with Walgreens corner store presence and trusted pharmacy services,” the companies said by statement.